158 related articles for article (PubMed ID: 24086757)
1. The T-cell oncogene Tal2 Is a Target of PU.1 and upregulated during osteoclastogenesis.
Courtial N; Mücke C; Herkt S; Kolodziej S; Hussong H; Lausen J
PLoS One; 2013; 8(9):e76637. PubMed ID: 24086757
[TBL] [Abstract][Full Text] [Related]
2. The paralogous hematopoietic regulators Lyl1 and Scl are coregulated by Ets and GATA factors, but Lyl1 cannot rescue the early Scl-/- phenotype.
Chan WY; Follows GA; Lacaud G; Pimanda JE; Landry JR; Kinston S; Knezevic K; Piltz S; Donaldson IJ; Gambardella L; Sablitzky F; Green AR; Kouskoff V; Göttgens B
Blood; 2007 Mar; 109(5):1908-16. PubMed ID: 17053063
[TBL] [Abstract][Full Text] [Related]
3. PU.1 and NFATc1 mediate osteoclastic induction of the mouse beta3 integrin promoter.
Crotti TN; Sharma SM; Fleming JD; Flannery MR; Ostrowski MC; Goldring SR; McHugh KP
J Cell Physiol; 2008 Jun; 215(3):636-44. PubMed ID: 18288635
[TBL] [Abstract][Full Text] [Related]
4. TAL1, TAL2 and LYL1: a family of basic helix-loop-helix proteins implicated in T cell acute leukaemia.
Baer R
Semin Cancer Biol; 1993 Dec; 4(6):341-7. PubMed ID: 8142619
[TBL] [Abstract][Full Text] [Related]
5. The hematopoietic transcription factor PU.1 regulates RANK gene expression in myeloid progenitors.
Kwon OH; Lee CK; Lee YI; Paik SG; Lee HJ
Biochem Biophys Res Commun; 2005 Sep; 335(2):437-46. PubMed ID: 16083856
[TBL] [Abstract][Full Text] [Related]
6. Tal1 regulates osteoclast differentiation through suppression of the master regulator of cell fusion DC-STAMP.
Courtial N; Smink JJ; Kuvardina ON; Leutz A; Göthert JR; Lausen J
FASEB J; 2012 Feb; 26(2):523-32. PubMed ID: 21990371
[TBL] [Abstract][Full Text] [Related]
7. TAL2, a helix-loop-helix gene activated by the (7;9)(q34;q32) translocation in human T-cell leukemia.
Xia Y; Brown L; Yang CY; Tsan JT; Siciliano MJ; Espinosa R; Le Beau MM; Baer RJ
Proc Natl Acad Sci U S A; 1991 Dec; 88(24):11416-20. PubMed ID: 1763056
[TBL] [Abstract][Full Text] [Related]
8. Angiopoietin-2 is a direct transcriptional target of TAL1, LYL1 and LMO2 in endothelial cells.
Deleuze V; El-Hajj R; Chalhoub E; Dohet C; Pinet V; Couttet P; Mathieu D
PLoS One; 2012; 7(7):e40484. PubMed ID: 22792348
[TBL] [Abstract][Full Text] [Related]
9. [Expression and Regulation of Tal2 during Neuronal Differentiation in P19 Cells].
Kobayashi T
Yakugaku Zasshi; 2017; 137(1):61-71. PubMed ID: 28049897
[TBL] [Abstract][Full Text] [Related]
10. Genetic and physical interactions between Microphthalmia transcription factor and PU.1 are necessary for osteoclast gene expression and differentiation.
Luchin A; Suchting S; Merson T; Rosol TJ; Hume DA; Cassady AI; Ostrowski MC
J Biol Chem; 2001 Sep; 276(39):36703-10. PubMed ID: 11481336
[TBL] [Abstract][Full Text] [Related]
11. Forced FOG1 expression in erythroleukemia cells: Induction of erythroid genes and repression of myelo-lymphoid transcription factor PU.1.
Fujiwara T; Sasaki K; Saito K; Hatta S; Ichikawa S; Kobayashi M; Okitsu Y; Fukuhara N; Onishi Y; Harigae H
Biochem Biophys Res Commun; 2017 Apr; 485(2):380-387. PubMed ID: 28216155
[TBL] [Abstract][Full Text] [Related]
12. Cooperation of PU.1 With IRF8 and NFATc1 Defines Chromatin Landscapes During RANKL-Induced Osteoclastogenesis.
Izawa N; Kurotaki D; Nomura S; Fujita T; Omata Y; Yasui T; Hirose J; Matsumoto T; Saito T; Kadono Y; Okada H; Miyamoto T; Tamura T; Aburatani H; Tanaka S
J Bone Miner Res; 2019 Jun; 34(6):1143-1154. PubMed ID: 30721543
[TBL] [Abstract][Full Text] [Related]
13. Products of the TAL2 oncogene in leukemic T cells: bHLH phosphoproteins with DNA-binding activity.
Xia Y; Hwang LY; Cobb MH; Baer R
Oncogene; 1994 May; 9(5):1437-46. PubMed ID: 8152805
[TBL] [Abstract][Full Text] [Related]
14. MITF and PU.1 recruit p38 MAPK and NFATc1 to target genes during osteoclast differentiation.
Sharma SM; Bronisz A; Hu R; Patel K; Mansky KC; Sif S; Ostrowski MC
J Biol Chem; 2007 May; 282(21):15921-9. PubMed ID: 17403683
[TBL] [Abstract][Full Text] [Related]
15. The macrosialin promoter directs high levels of transcriptional activity in macrophages dependent on combinatorial interactions between PU.1 and c-Jun.
Li AC; Guidez FR; Collier JG; Glass CK
J Biol Chem; 1998 Feb; 273(9):5389-99. PubMed ID: 9479000
[TBL] [Abstract][Full Text] [Related]
16. Nuclear factor of activated T cells c1 induces osteoclast-associated receptor gene expression during tumor necrosis factor-related activation-induced cytokine-mediated osteoclastogenesis.
Kim K; Kim JH; Lee J; Jin HM; Lee SH; Fisher DE; Kook H; Kim KK; Choi Y; Kim N
J Biol Chem; 2005 Oct; 280(42):35209-16. PubMed ID: 16109714
[TBL] [Abstract][Full Text] [Related]
17. Enforced expression of PU.1 rescues osteoclastogenesis from embryonic stem cells lacking Tal-1.
Tsuneto M; Tominaga A; Yamazaki H; Yoshino M; Orkin SH; Hayashi S
Stem Cells; 2005; 23(1):134-43. PubMed ID: 15625130
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional regulation of Tal2 gene by all-trans retinoic acid (atRA) in P19 cells.
Kobayashi T; Suzuki M; Morikawa M; Kino K; Tanuma S; Miyazawa H
Biol Pharm Bull; 2015; 38(2):248-56. PubMed ID: 25482166
[TBL] [Abstract][Full Text] [Related]
19. Microphthalmia transcription factor and PU.1 synergistically induce the leukocyte receptor osteoclast-associated receptor gene expression.
So H; Rho J; Jeong D; Park R; Fisher DE; Ostrowski MC; Choi Y; Kim N
J Biol Chem; 2003 Jun; 278(26):24209-16. PubMed ID: 12695521
[TBL] [Abstract][Full Text] [Related]
20. Tal2 expression is induced by all-trans retinoic acid in P19 cells prior to acquisition of neural fate.
Kobayashi T; Komori R; Ishida K; Kino K; Tanuma S; Miyazawa H
Sci Rep; 2014 May; 4():4935. PubMed ID: 24816818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
